Innovative therapeutics

Investors

SEC Filings

NASDAQBMRN
FormDescriptionDateFormat
4Statement of changes in beneficial ownership of securitiesAug 24, 2010View HTMLDownload DOCDownload PDF
CT ORDERConfidential treatment orderAug 23, 2010View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventAug 23, 2010View HTMLDownload DOCDownload PDFDownload XLS
CORRESPCorrespondence from the Filer to the SECAug 13, 2010View HTMLDownload DOCDownload PDFDownload XLS
S-8Securities offered to employees pursuant to employee benefit plansAug 5, 2010View HTMLDownload DOCDownload PDFDownload XLS
10-QQuarterly report which provides a continuing view of a company's financial positionAug 4, 2010View HTMLDownload DOCDownload PDFDownload XLSView XBRLDownload XBRL
4Statement of changes in beneficial ownership of securitiesAug 3, 2010View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventAug 2, 2010View HTMLDownload DOCDownload PDFDownload XLS
UPLOADCorrespondence from the SEC to the FilerJul 30, 2010Download DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 28, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 26, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 23, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 9, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 8, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 8, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 8, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 8, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 8, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 3, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 14, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 14, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 14, 2010View HTMLDownload DOCDownload PDF
CT ORDERConfidential treatment orderMay 14, 2010View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventMay 14, 2010View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesMay 14, 2010View HTMLDownload DOCDownload PDF
1-25      26-50      51-75      76-100      101-123

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information